Can a Place of Origin of the Main Cystic Fibrosis Mutations Be Identified?  by Mateu, Eva et al.
Am. J. Hum. Genet. 70:257–264, 2002
257
Report
Can a Place of Origin of the Main Cystic Fibrosis Mutations Be Identified?
Eva Mateu,1 Francesc Calafell,1 Maria Dolors Ramos,2 Teresa Casals,2 and Jaume Bertranpetit1
1Unitat de Biologia Evolutiva, Facultat de Cie`ncies de la Salut i de la Vida, Universitat Pompeu Fabra, and 2Departament de Gene`tica
Molecular, Institut de Recerca Oncolo`gica, Barcelona
The genetic background of the mutations that most often cause cystic fibrosis (CF) is different from that of non-
CF chromosomes in populations of European origin. It is not known whether these haplotype backgrounds could
be found at high frequencies in populations in which CF is, at present, not common; such populations would be
candidates for the place of origin of CF mutations. An analysis of haplotypes of CF transmembrane conductance
regulator, together with their variation in specific CF chromosomes, in a worldwide survey of normal chromosomes
shows (1) a very low frequency or absence of the most common CF haplotypes in all populations analyzed and
(2) a strong genetic variability and divergence, among various populations, of the chromosomes that carry disease-
causing mutations. The depth of the gene genealogy associated with disease-causing mutations may be greater than
that of the evolutionary process that gave rise to present-day human populations. The concept of “population of
origin” lacks either spatial or temporal meaning for mutations that are likely to have been present in Europeans
before the ethnogenesis of present populations; subsequent population processes may have erased the traces of their
geographic origin.
A deep understanding of a genetic disease requires not
only a comprehension of its genetic and functional bases
but also a description of its natural history. Ideally, such
a description would comprise the place and time of or-
igin of the pathogenic genetic variant and an explanation
of its presence, frequency, and geographic distribution.
Natural history also includes the genetic mechanisms
that may explain the appearance of the disease (such as
mutation rate and pattern), the population factors that
may explain disease frequency and distribution (migra-
tion, population size, and genetic drift), and the inter-
action with the environment (selection in its rich variety).
Cystic fibrosis (CF [MIM 219700]) is the most com-
mon severe autosomal recessive disease in popula-
tions of European origin, in which it affects 1 in
2,500 individuals. It is caused by mutations in the CF
transmembrane conductance regulator (CFTR [MIM
602421]), which was identified and cloned in 1989
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(Kerem et al. 1989; Riordan et al. 1989; Rommens et
al. 1989). Since then, ∼1,000 mutations have been re-
ported (Cystic Fibrosis Mutation Data Base). Among the
various CF mutations, a deletion of 3 bp at codon 508
(DF508) is the most frequent, accounting for two-thirds
of the global CF chromosomes. Only four other muta-
tions (G542X, N1303K, G551D, and W1282X) have
overall frequencies 11% among the CF chromosomes.
These five mutations are found throughout Europe, al-
though their distribution shows clear geographic pat-
terns: DF508 shows a northwest-to-southeast gradient,
with a maximum (87.2% of all CF chromosomes) in
Denmark and a minimum (21.3%) in Turkey (European
Working Group on CF Genetics 1990). G542X is com-
mon in Mediterranean countries and is present in most
of Europe, being most frequent (16.7%) in the Balearic
Islands (Estivill et al. 1997). N1303K is present around
the Mediterranean, and it reaches its highest frequency
(17.2%) in Tunisia (Estivill et al. 1997). Mutation
G551D is common in northwestern and central Europe,
but it is uncommon in other parts of Europe (Estivill et
al. 1997). Finally, mutationW1282X is common in most
Mediterranean countries, reaching its highest frequency
(36.2%) in Israel (Estivill et al. 1997). In addition, 17
other mutations have frequencies of 0.1%–0.9% (Estiv-
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Figure 1 Polymorphisms in the CFTR region (IVS1CA, IVS6aGATT, IVS8CA, T854, IVS17bTA, and TUB20), and location of the five
most common CF mutations (DF508, G542X, N1303K, G551D, and W1282X). CFTR exons are numbered 1–24.
ill et al. 1997), and most of the remaining mutations are
rare or are confined to few populations.
Several short tandem-repeat polymorphisms (STRPs),
which are also known as “microsatellites,” and single-
nucleotide polymorphisms (SNPs) have been described
within the CFTR gene. Both types of markers can be
used to trace the origin and evolution of the different
CF mutations (Morral et al. 1993; Morral et al. 1994;
Bertranpetit and Calafell 1996; Slatkin and Rannala
1997). SNPs can be used to define the stable haplotypic
frameworks on which CFTR mutations occurred. Mi-
crosatellite markers, which mutate faster and are more
diverse among chromosomes, can help to measure ge-
netic variability within the CFTR locus and to estimate
the age of CF mutations (Morral et al. 1993; Estivill et
al. 1994; Bertranpetit and Calafell 1996).
When nondisease chromosomes (usually nondisease
chromosomes of carriers) were analyzed in the popu-
lations in which CF is present, it became evident that,
among Europeans, the general genetic background was
very different from that of CF chromosomes (Estivill et
al. 1994; Morral et al. 1996). Because CF is mostly con-
fined to populations of European ancestry, it seemed
likely that the origin of the most frequent CF mutations
should be non-European (Morral et al. 1994) and that
subsequent gene flow had brought CF chromosomes into
Europe.
A hypothesis based on natural selection has been sug-
gested to explain the high prevalence of CF: heterozy-
gotes for CF mutations would be protected against the
dehydrating action of Vibrio cholerae (Romeo et al.
1989; Gabriel et al. 1994) or Salmonella typhi (Pier et
al. 1998; Pier 1999, 2000) enterotoxins, although this
has been disputed (Ho¨genauer et al. 2000). Protection
against cholera or typhoid fever would make it more
likely that selective pressures raised the CF frequency
outside Europe, where these diseases are more prevalent;
this is an argument for a non-European origin of CF.
Because the haplotypic backgrounds on which major
CF mutations occurred have been clearly identified
(Morral et al. 1996), we undertook a worldwide survey,
to find populations in which specific haplotypes linked
to CF mutations would be present at high frequencies.
This could give hints about past specific selective pres-
sures that could explain the spread of the mutations.
Given that recombination rates in 7q31.2 (the chro-
mosome region where CFTR maps) are one-fifth of the
genome average (Payseur and Nachman 2000), it is un-
likely that recombination disrupted the allelic associa-
tions in this region. Moreover, recombinant haplotypes,
because of their high polymorphism, are easily detected
with these markers (Morral et al. 1994).
We analyzed four STRPs and two SNPs located within
CFTR (fig. 1). These are, in 5′r3′ chromosomal order,
IVS1CA (Moulin et al. 1997; Mateu et al. 1999),
IVS6aGATT (Chehab et al. 1991), IVS8CA (Morral et
al. 1991), T854 (Zielenski et al. 1991b), IVS17bTA (Zie-
lenski et al. 1991a), and TUB20 (Quere et al 1991). We
typed samples from 949 unrelated autochthonous
healthy individuals (1,898 chromosomes) from 17 pop-
ulations that represented all major geographic areas (fig.
2). Appropriate informed consent was obtained from
human subjects. DNA from five populations (Basque,
Catalan, Tanzanian, Kazakh, and Saharawi) was ex-
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Figure 2 Distribution of 17 populations analyzed. Population names (sample sizes [no. of chromosomes]) are as follows: ADYp Adygei
(106); BAS p Basques (222); BIA p Biaka Pygmies (138); CAT p Catalans (176); CHI p Han Chinese (124); DRU p Druze (126); FINp
Finns (70); JPN p Japanese (96); KAZ p Kazakhs (80); MAY p Maya (106); MBU p Mbuti Pygmies (78); RUS p Russians (96); SAHp
Saharawi (118); SUR p Surui (94); TAN p Tanzanians (80); YAK p Yakut (102); YEM p Yemenites (86). Further information on these
population samples can be found in the Allele Frequency Database and in a report by Mateu et al. (2001).
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21 .993 1 .941
22 0 0 .059
23 .007 0 0
NOTE.—Numbers of chromosomes studied
appear in parentheses.
tracted from fresh blood of donors. DNA samples for
the other populations were obtained from lymphoblas-
toid cell lines maintained in K. K. Kidd’s laboratory at
Yale University. Because no disease chromosomes had
yet been typed for the more recently described IVS1CA
marker, a total of 126 patients (252 chromosomes), who
carried the DF508, G542X, and/or N1303K mutations,
were typed for this locus. Allele frequencies for this locus
are reported here, for the first time, in chromosomes
carrying CF mutations. The samples were obtained at
the Institut de Recerca Oncolo`gica, Barcelona.
Typing methods for six loci are as described elsewhere
(Mateu et al. 2001), in an article in which we have re-
ported allele and haplotype frequencies for the popu-
lation set. Mean maximum-likelihood estimates of hap-
lotype frequencies and the jackknife standard errors
(SEs) were calculated from the multisite marker–typing
data, by the HAPLO program (Hawley and Kidd 1995).
We used PHYLIP (Felsenstein 1989) to produce maxi-
mum-likelihood population trees of allele frequencies of
five polymorphisms (no data were available for IVS1CA,
for chromosomes carrying G551D or W1282X) of nor-
mal and CF chromosomes. IVS6aGATT, IVS8CA, T854,
IVS17bTA, and TUB20 allele frequencies for CF chro-
mosomes (with DF508, G542X, N1303K, G551D, and
W1282X mutations) were obtained from the literature
(Morral et al. 1994, 1996). IVS8CA and IVS17bTA al-
lele frequencies for DF508 chromosomes in geographi-
cally defined samples for European populations were
from Morral et al. (1994).
Allele frequencies for the intron 1 CA repeat in CF
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Table 2
Most Frequent CFTR Haplotype(s) for the Five Most Common CF Mutations
CF MUTATION
HAPLOTYPE(S) AT MARKERa
IVS1CA IVS6aGATT IVS8CA T854 IVS17bTA TUB20
DF508 21 6 23/17 1 31/32 2
G542X 21 6 23 1 33/32 2
N1303K 21 6 23/22/24 1 31 2
G551D NA 7 16 2 7 1
W1282X NA 7 17 2 7 1
a IVS1CA was typed in the present study. The remaining markers were typed byMorral
et al. (1996). NA p not available.
Table 4
Frequencies, Normal Chromosomes, of
Haplotypes 7-16/17-2-7-1, Associated with CF
Mutations G551D and W1282X
Population
Mean Frequency  SE
(%)
Tanzanians 3.2  2.2
Biaka 9  2.6
Mbuti 12  4
Saharawi 20.8  3.9
Druze 15.1  3.2
Yemenites 7.5  2.9
Basques 11.2  2.1
Catalans 16.7  2.9
Finns 16.1  4.7
Russians 15  4.6
Adygei 17.3  3.8
Kazakhs 6.7  3.2
Yakut 2.6  1.8
NOTE.— The frequency in the populations not
listed is zero.
Table 3
Frequencies, in Normal Chromosomes, of Haplotypes Associated
with CF Mutations DF508, G542X, and N1303K
POPULATION
MEAN FREQUENCY (SE) IN HAPLOTYPE
(%)a
A B C D
Druze 2.4  1.4 0 4  1.7 0
Basque 0 0 4.2  1.4 0
Catalan 0 0 1.4  .9 .6  .6
Finnish 0 1.6  1.6 3.2  2.2 1.6  1.6
Russian 0 0 1.7  1.7 1.7  1.7
Adygei 0 0 2.0  1.4 0
Japanese 0 0 0 1.2  1.2
NOTE.—The frequency in the populations not listed is zero.
a Haplotype A p 21-6-23-1-31-2; haplotype B p 21-6-17-1-31-
2; haplotype C p (20/21/22)-6-(22/23/24)-1-(30/31/32/33/34)-2;
and haplotype D p (20/21/22)-6-(16/17/18)-1-(30/31/32)-2.
chromosomes are given in table 1. The three most com-
mon mutations are clearly associated with the 21-repeat
allele, which is likely to have been present in the hap-
lotype backgrounds where these mutations originated.
The most frequent CF-causing mutations are found in
two groups of haplotype backgrounds (table 2). When
all six markers are considered in their chromosomal
order (i.e., IVS1CA, IVS6aGATT, IVS8CA, T854,
IVS17bTA, and TUB20), these haplotype background
groups are: (1) 21-6-(17/22/23/24)-1-(31/32/33)-2, of
which the most frequent are 21-6-23-1-31-2 (for DF508
and N1303K mutations) and 21-6-23-1-33-2 (for the
G542X mutation) it is evident that these three different
CF mutations (which have independent origins) are
found in very closely related haplotypes, since they differ
only by a few repeat units at the fast-evolving STRP
sites; and (2) 7-(16/17)-2-7-1, in which G551D and
W1282X are found. For these mutations, no data are
available for IVS1CA, the first marker.
The haplotypes associated specifically with DF508,
even if several alleles for the STRs are pooled, are not
found in frequencies that would suggest a place of likely
origin for DF508 in any of the populations sampled (ta-
ble 3). These haplotypes have been found—at very low
frequencies—only in one Middle Eastern population
(Druze, 2.4%) and in one European population (Finns,
1.6%). The most common haplotypes in European and
Middle Eastern populations are 21-7-16-2-7-1 and 22-
7-16-1-30-2, which have allele frequencies of 9.4% and
19.7%, respectively (Mateu et al. 2001). Only minor
traces of chromosomes that bear phylogenetically related
haplotypes are found in several European and Asian
populations (table 3).
Haplotypes associated with CF mutations G542X and
N1303K are closely related to those of DF508, and the
situation is therefore similar. This suggests that all three
mutations arose in the same population. When the three
haplotype backgrounds are considered together (a strat-
egy that permits examination of a deeper branch in the
gene tree of haplotypes), frequencies in normal chro-
mosomes remain at very low levels (table 3). Given the
sample size, some of these haplotypes could be present
in the populations but not included in the sample. For
sample sizes of 70–222 chromosomes, a nonobserved
haplotype could have, with a 95% probability, an upper
frequency of 4.19%–1.34% (Rohlf and Sokal 1995).
Thus, haplotypes found at frequencies of the same order
Reports 261
Figure 3 Maximum-likelihood tree of allele frequencies of five loci (IVS6aGATT, IVS8CA, T854, IVS17bTA and TUB20) among normal
chromosomes, from worldwide populations, and among CF chromosomes (DF508, G542X, N1303K, G551D and W1282X chromosomes).
The inset shows an enlarged maximum-likelihood tree of allele frequencies of two loci (IVS8CA and IVS17bTA) among DF508 chromosomes
in different European populations (Fbas p Basque; Fbri p British; Fbul p Bulgarian; Fcze p Czech; Fdenp Danish; Ffinp Finnish; Ffrap
French; Fger p German; Fhun p Hungarian; Fire p Irish; Fita p Italian; Fslo p Slovakian; Fspa p Spanish; Fswe p Swedish). Bars show
the scale in genetic-distance units. Several trees have been built, using either other methods (e.g., Nei-Kimura distance and the neighbor-joining
algorithm) or different sets of chromosomes. In all cases, results are similar.
of magnitude as the CF carrier frequency in the popu-
lation would be detected. It should be noted that a signal
of the origin of any of the three major mutations in a
population would be a frequency clearly above that,
since all three mutations seem to have occurred on the
same background, an event that would be quite im-
probable if the haplotype frequency were so low. Alter-
natively, that particular haplotype may be mutagenic,
which, in absence of other kinds of biological evidence,
seems implausible; it has been clearly demonstrated that
they have a single origin (Morral et al. 1993; Bertranpetit
and Calafell 1996).
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The situation is very different for the two other
frequent mutations (G551D and W1282X). Both are
associated with closely related haplotypes, now found
at high frequency in populations of different conti-
nents (table 4): Africa (Mbuti, 12%; Saharawi,
20.8%), western Asia (Adygei, 17.3%), Europe (Cat-
alans, 16.7%), and Siberia (Yakut, 2.6%). They have
not been found in other populations of eastern Asian
or in American Indians.
To further explore the population-genetics relation-
ships, a tree was built using maximum likelihood, in-
cluding allele frequencies for non-CF chromosomes and
for chromosomes carrying specific CF mutations; in the
case of DF508, it has been possible to consider different
European populations separately (fig. 3). The structure
of the variation is mainly based on haplotype back-
ground (not on population). Thus, it appears that
DF508, G542X, and N1303K are closely related to each
other, as are G551D and W1282X, independently of the
population from which chromosomes were sampled. A
similar pattern has been observed for other genome
regions (Bosch et al. 1999). The main stratifying factor
is genetic background (i.e., presence or absence of CF
mutations), rather than population, even when very dis-
tant populations are considered.
The present results of a worldwide genetic survey
show that the main CF-mutation haplotype back-
grounds either are found at very low frequencies or,more
usually, are altogether absent. Although no population
has them in frequencies high enough to suggest a likely
place of origin, it should be kept in mind that mutations
DF508, G542X, and N1303K are independent unique
events and that their occurrence in a similar background
gives support to the hypothesis that the three mutations
arose in a single population in which these haplotypes
were frequent. In that hypothetical population, demo-
graphic events (such as expansion) or selective agents
could have raised those deleterious mutations to rela-
tively high frequencies and could have spread them to
other areas.
The current widespread distribution of haplotypes re-
lated to G551D and W1282X is compatible with an
origin in Europe, although a geographic distribution that
would allow us to identify the birthplace of these mu-
tations is not evident. Moreover, given the low frequency
of these mutations, no localized selection pressures need
to be invoked to explain their origin and current
distribution.
The maximum-likelihood tree for CF and non-CF
chromosomes (fig. 3) stresses the importance of the ge-
netic background as well as the lesser importance of the
population in which the individual (or, more precisely,
a chromosome) belongs. The age of DF508 is contro-
versial, with estimates ranging from 3,000 years ago (i.e.,
post-Neolithic era) (Serre et al. 1990) to 140,000 years
ago (in the Upper Paleolithic era, and clearly pre-Neo-
lithic) (Morral et al. 1994). A recent study, using coa-
lescence theory (Wiuf 2001), has confirmed an ancient
age for the mutation, with estimates ranging from
11,000 to 34,000 years ago. Using standard population-
genetics models, Reich and Lander (2001) have also es-
timated—on the basis of the overall frequency of CF
alleles—that DF508 may predate the expansion of an-
atomically modern humans. Even though the estimates
are strongly dependent on genetic (e.g., mutation rate
and selection) and demographic (e.g., expansion dynam-
ics and population size) parameters, the mutation is
clearly pre-Neolithic and is an ancient mutation in hu-
man history. Other CF mutations are slightly younger
(Morral et al. 1993). The estimates for older mutations
are in agreement with the stronger genetic-variation dif-
ferentiation shown by CF mutations.
The problem of the place or population of origin of
the most common CF mutations may lack sense, because
several of them may be older (Morral et al. 1994; Wiuf
2001) than the ethnogenesis process that originated the
present European populations (Cavalli-Sforza et al.
1994). Thus, population processes such as genetic drift
and gene flow, may have had sufficient time to reshape
the genetic structure of the population in which the ma-
jor CF mutations arose. Indeed, they may have erased
the traces that could lead to the identification of a pop-
ulation as the cradle of CF mutations. Given that the
mutations are ancient and that genetic variation in CF
chromosomes is structured by lineage rather than by
population origin, a population-genetic approach may
not produce results adequate for a detailed comprehen-
sion of the evolutionary processes that gave rise to CF
mutations.
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